Limax Biosciences, Inc.
Limax Biosciences is dedicated to revolutionizing tissue healing through innovative biomaterials inspired by the natural slime of slugs. Their hydrogels provide superior adhesion and healing capabilities, addressing unmet medical needs both inside and outside the body.
Industries
Nr. of Employees
small (1-50)
Limax Biosciences, Inc.
Limax Biosciences, Inc. is currently seeking investment
Limax Biosciences, Inc. is seeking a seed investment in the range of 1m-5m
Products
Biodegradable tough gel tissue adhesive
A biodegradable hydrogel adhesive designed to seal tissue leaks, promote wound healing, and enable localized drug delivery; engineered for wet adhesion, mechanical toughness, stretchability, rapid setting, and tunability.
Biodegradable tough gel tissue adhesive
A biodegradable hydrogel adhesive designed to seal tissue leaks, promote wound healing, and enable localized drug delivery; engineered for wet adhesion, mechanical toughness, stretchability, rapid setting, and tunability.
Expertise Areas
- Tissue adhesive development
- Biomaterials research and development
- Hemostasis and surgical bleeding control
- Wound healing and tissue repair
Key Technologies
- Hydrogel-based tissue adhesives
- Double-network/tough hydrogel architectures
- Stretchable hydrogel systems
- Rapid-setting adhesive chemistries
Key People
Benjamin Freedman, PhD
Co-founder
David Mooney, PhD
Co-founder
Phoebe Kwon
Research Scientist
Christopher Johnson
Support/Consultant
Adam Hacking, PhD
Advisor
Anh Hoang, PhD
Advisor
Benjamin Freedman, PhD
Co-founder
David Mooney, PhD
Co-founder
Phoebe Kwon
Research Scientist
Christopher Johnson
Support/Consultant
Adam Hacking, PhD
Advisor
Anh Hoang, PhD
Advisor
Investors
MedTech Innovator
Announced on 2022-06-07.
MedTech Innovator
Announced on 2022-06-07.
News & Updates
Grants Awarded
Grants have been awarded by the Bill & Melinda Gates Foundation and by NSF Innovation Corps for Customer Discovery and Validation.
Winner of Innovation Challenges
Limax was the winner in Harvard University President's Innovation Challenge (2022), MassChallenge (2023), MedTech Innovator (Value Competition, 2022), and Advanced Technology International (ATI) and TechConnect's Medical Innovation Challenge (2022).
Accelerator Programs
Limax Biosciences is a member of the JLabs family as a QuickFire Challenge Award Recipient.
1st Place in Harvard President's Innovation Challenge
Limax Biosciences team won first-place prize in the Health & Life Sciences Track of the 2022 Harvard President's Innovation Challenge.
Grants Awarded
Grants have been awarded by the Bill & Melinda Gates Foundation and by NSF Innovation Corps for Customer Discovery and Validation.
Winner of Innovation Challenges
Limax was the winner in Harvard University President's Innovation Challenge (2022), MassChallenge (2023), MedTech Innovator (Value Competition, 2022), and Advanced Technology International (ATI) and TechConnect's Medical Innovation Challenge (2022).
Accelerator Programs
Limax Biosciences is a member of the JLabs family as a QuickFire Challenge Award Recipient.
1st Place in Harvard President's Innovation Challenge
Limax Biosciences team won first-place prize in the Health & Life Sciences Track of the 2022 Harvard President's Innovation Challenge.